fashion -WSS

fashion

author：hotspot 2025-09-28 21:54:25 - browse：67

Daphne Koller -- biotech coverage from STAT — Daphne Koller, early biotech AI entrant Insitro's founder, CEO and board member. Courtesy Jerrick Mitra/Insitro

New artificial intelligence technologies made headlines last year for their ability to do everything from generating fake musical duets to understanding how proteins fold. But in biotech, one of the most well-funded AI players has been quiet.

Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera. It raised more than $643 million in venture capital, according to PitchBook, from investors including T. Rowe Price, ARCH Venture Partners, and Casdin Capital. The company now has more than 260 employees spread out over 107,000 square feet of laboratory and office space.

But what exactly is Koller building?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： AstraZeneca loses challenge to Medicare drug price negotiation

entertainment

WSS

Kenai launches with $82 million for Parkinson’s stem cell therapy

Pfizer's Covid pill remains 89% effective in final analysis, company says

New case study details death in closely watched Alzhiemer's trial

Grail is spending more than ever lobbying Congress

Kenai launches with $82 million for Parkinson’s stem cell therapy

A Q&A with Aletha Maybank, AMA’s chief health equity officer

knowledge

fashion

focus

Alkermes shareholders re

Connecting traumatic brain injury and domestic violence

Novavax promises a turnaround & Lilly roils the obesity market

Meta looks to target Twitter with a rival app called Threads

Guidelines to prevent youth baseball injuries need more muscle

RaDonda Vaught to speak at CommonSpirit event on patient safety

ChatGPT in medicine: STAT answers readers' burning questions

Grail is spending more than ever lobbying Congress

Psychedelics group wrestles with new pharma identity

Obesity now affects over 1 billion people worldwide, study finds

Wikipedia

Why getting cancer drugs just got harder for rural patients

How to address the problem of discarded donor organs

Obesity now affects over 1 billion people worldwide, study finds

ALS groups 'won't be played again' by the FDA, drug sponsors

Pfizer highlights cancer drugs it thinks could reignite investor interest

New case study details death in closely watched Alzhiemer's trial

leisure time

hotspot

entertainment

hotspot